Warning: The NCBI web site requires JavaScript to function. more...
Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors.
Rhee SY, Liu TF, Kiuchi M, Zioni R, Gifford RJ, Holmes SP, Shafer RW.
Retrovirology. 2008 Aug 7;5:74.
Related citations
Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
Lataillade M, Chiarella J, Kozal MJ.
Antivir Ther. 2007;12(4):563-70.
Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.
AIDS Rev. 2009 Jan-Mar;11(1):17-29. Review.
Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
Brenner BG, Lowe M, Moisi D, Hardy I, Gagnon S, Charest H, Baril JG, Wainberg MA, Roger M.
J Med Virol. 2011 May;83(5):751-9. doi: 10.1002/jmv.22047. Epub 2011 Feb 25.
Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drug-naïve patients with HIV/AIDS in Korea.
Kim JY, Kim EJ, Choi JY, Kwon OK, Kim GJ, Choi SY, Kim SS.
Clin Microbiol Infect. 2011 Aug;17(8):1155-9. doi: 10.1111/j.1469-0691.2010.03392.x. Epub 2010 Dec 3.
HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir.
Varghese V, Liu TF, Rhee SY, Libiran P, Trevino C, Fessel WJ, Shafer RW.
AIDS Res Hum Retroviruses. 2010 Dec;26(12):1323-6. Epub 2010 Oct 21.
Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.
Low A, Prada N, Topper M, Vaida F, Castor D, Mohri H, Hazuda D, Muesing M, Markowitz M.
Antimicrob Agents Chemother. 2009 Oct;53(10):4275-82. Epub 2009 Aug 3.
Natural polymorphisms of integrase among HIV type 1-infected South African patients.
Fish MQ, Hewer R, Wallis CL, Venter WD, Stevens WS, Papathanasopoulos MA.
AIDS Res Hum Retroviruses. 2010 Apr;26(4):489-93.
Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase.
Myers RE, Pillay D.
J Virol. 2008 Sep;82(18):9228-35. Epub 2008 Jul 2.
Lack of primary mutations associated with integrase inhibitors among HIV-1 subtypes B, C, and F circulating in Brazil.
Passaes CB, Guimarães ML, Fernandez SL, Lorete Rdos S, Teixeira SL, Fernandez JC, Morgado MG.
J Acquir Immune Defic Syndr. 2009 May 1;51(1):7-12.
Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.
Garrido C, Geretti AM, Zahonero N, Booth C, Strang A, Soriano V, De Mendoza C.
J Antimicrob Chemother. 2010 Feb;65(2):320-6. Epub 2009 Dec 9.
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients.
Piralla A, Paolucci S, Gulminetti R, Comolli G, Baldanti F.
Virol J. 2011 Mar 31;8:149.
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, Mboup S, Mulanga-Kabeya C, Saman E, Jourdan J, Reynes J, Delaporte E.
J Clin Microbiol. 2000 Nov;38(11):3919-25.
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.
Tschochner M, Chopra A, Maiden TM, Ahmad IF, James I, Furrer H, Günthard HF, Mallal S, Rauch A, John M.
Antivir Ther. 2009;14(7):953-64.
HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure.
van Hal SJ, Herring B, Deris Z, Wang B, Saksena NK, Dwyer DE.
Retrovirology. 2009 Feb 9;6:12.
Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in São Paulo City, Brazil.
Arruda LB, Fonseca LA, Duarte AJ, Casseb J.
AIDS Res Hum Retroviruses. 2010 Jan;26(1):105-7.
Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.
Nouhin J, Donchai T, Hoang KT, Ken S, Kamkorn J, Tran T, Ayouba A, Peeters M, Chaix ML, Lien TX, Nerrienet E, Ngo-Giang-Huong N.
Infect Genet Evol. 2011 Jan;11(1):38-43. Epub 2010 Nov 19.
Genotypic prediction of resistant mutation in HIV-1 pol gene towards the antiretroviral drugs.
Kumar A, Jadhav C.
Int J Bioinform Res Appl. 2011;7(1):15-23.
Potential drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A.
Herring BL, Cunningham AL, Dwyer DE.
AIDS Res Hum Retroviruses. 2004 Sep;20(9):1010-4.
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
Ceccherini-Silberstein F, Malet I, Fabeni L, Dimonte S, Svicher V, D'Arrigo R, Artese A, Costa G, Bono S, Alcaro S, Monforte A, Katlama C, Calvez V, Antinori A, Marcelin AG, Perno CF.
J Antimicrob Chemother. 2010 Nov;65(11):2305-18. Epub 2010 Sep 3.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on